BACKGROUND: Gastric reflux can reach into the upper airway, inducing cellular damage in the epithelial lining. This condition is believed to be a risk factor for development of laryngopharyngeal squamous cell carcinoma (LPSCC), although the literature is conflicting. METHODS: To better clarify this relationship, we assessed the association of self-reported heartburn history and medication use among 631 patients with LPSCCs and 1234 control subjects (frequency-matched on age, gender, and town of residence) enrolled as part of a population-based case-control study of head and neck squamous cell carcinoma in the greater Boston area. RESULTS: After adjusting for age, gender, race, smoking, alcohol consumption, HPV16 seropositivity, education, and body mass index, subjects reporting a history of frequent heartburn and who were neither a heavy smoker nor heavy drinker had a significantly elevated risk of LPSCCs [OR, 1.78; 95% confidence interval (CI), 1.00-3.16]. Among those with a history of heartburn, there was an inverse association between antacid use and LPSCCs relative to those never taking heartburn medication (OR, 0.59; 95% CI, 0.38-0.93) that remained consistent when analyzed by smoking/drinking status, HPV16 status, or by primary tumor site. CONCLUSIONS: Our data show that gastric reflux is an independent risk factor for squamous cancers of the pharynx and larynx. Further studies are needed to clarify the possible chemopreventive role of antacid use for patients with gastric reflux. IMPACT: Elucidation of additional risk factors for head and neck cancer can allow for risk stratification and inform surveillance of high-risk patients.
BACKGROUND: Gastric reflux can reach into the upper airway, inducing cellular damage in the epithelial lining. This condition is believed to be a risk factor for development of laryngopharyngeal squamous cell carcinoma (LPSCC), although the literature is conflicting. METHODS: To better clarify this relationship, we assessed the association of self-reported heartburn history and medication use among 631 patients with LPSCCs and 1234 control subjects (frequency-matched on age, gender, and town of residence) enrolled as part of a population-based case-control study of head and neck squamous cell carcinoma in the greater Boston area. RESULTS: After adjusting for age, gender, race, smoking, alcohol consumption, HPV16 seropositivity, education, and body mass index, subjects reporting a history of frequent heartburn and who were neither a heavy smoker nor heavy drinker had a significantly elevated risk of LPSCCs [OR, 1.78; 95% confidence interval (CI), 1.00-3.16]. Among those with a history of heartburn, there was an inverse association between antacid use and LPSCCs relative to those never taking heartburn medication (OR, 0.59; 95% CI, 0.38-0.93) that remained consistent when analyzed by smoking/drinking status, HPV16 status, or by primary tumor site. CONCLUSIONS: Our data show that gastric reflux is an independent risk factor for squamous cancers of the pharynx and larynx. Further studies are needed to clarify the possible chemopreventive role of antacid use for patients with gastric reflux. IMPACT: Elucidation of additional risk factors for head and neck cancer can allow for risk stratification and inform surveillance of high-risk patients.
Authors: Katerina Dvorak; Aaron Goldman; Jianping Kong; John P Lynch; Lloyd Hutchinson; Jean Marie Houghton; Hao Chen; Xiaoxin Chen; Kausilia K Krishnadath; Wytske M Westra Journal: Ann N Y Acad Sci Date: 2011-09 Impact factor: 5.691
Authors: Neela Guha; Paolo Boffetta; Victor Wünsch Filho; Jose Eluf Neto; Oxana Shangina; David Zaridze; Maria Paula Curado; Sergio Koifman; Elena Matos; Ana Menezes; Neonila Szeszenia-Dabrowska; Leticia Fernandez; Dana Mates; Alexander W Daudt; Jolanta Lissowska; Rajesh Dikshit; Paul Brennan Journal: Am J Epidemiol Date: 2007-08-30 Impact factor: 4.897
Authors: David O Francis; Charles Maynard; Ernest A Weymuller; Gayle Reiber; Albert L Merati; Bevan Yueh Journal: Laryngoscope Date: 2011-01 Impact factor: 3.325
Authors: J K McLaughlin; G Gridley; G Block; D M Winn; S Preston-Martin; J B Schoenberg; R S Greenberg; A Stemhagen; D F Austin; A G Ershow Journal: J Natl Cancer Inst Date: 1988-10-05 Impact factor: 13.506
Authors: Silvana Papagerakis; Emily Bellile; Lisa A Peterson; Maria Pliakas; Katherine Balaskas; Sara Selman; David Hanauer; Jeremy M G Taylor; Sonia Duffy; Gregory Wolf Journal: Cancer Prev Res (Phila) Date: 2014-12
Authors: Shao-Ming Wang; Neal D Freedman; Hormuzd A Katki; Charles Matthews; Barry I Graubard; Lisa L Kahle; Christian C Abnet Journal: Cancer Date: 2021-02-22 Impact factor: 6.921
Authors: Jayalakshmi Nair; Prachi Jain; Udita Chandola; Vinayak Palve; N R Harsha Vardhan; Ram Bhupal Reddy; Vikram D Kekatpure; Amritha Suresh; Moni Abraham Kuriakose; Binay Panda Journal: Genes Cancer Date: 2015-07
Authors: Scott M Langevin; Melissa Eliot; Rondi A Butler; Agnes Cheong; Xiang Zhang; Michael D McClean; Devin C Koestler; Karl T Kelsey Journal: Clin Epigenetics Date: 2015-12-03 Impact factor: 6.551